2018
DOI: 10.1016/j.clbc.2018.07.015
|View full text |Cite
|
Sign up to set email alerts
|

Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
32
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(37 citation statements)
references
References 29 publications
3
32
0
2
Order By: Relevance
“…Our data show 50.7% (346/683) RRSO uptake, which is consistent with literature reports of 12–78% 14,24,27,36,41–68 . Uptake was higher among older women, women who completed childbearing, those who had BC themselves, and those having undergone RRM.…”
Section: Discussionsupporting
confidence: 92%
“…Our data show 50.7% (346/683) RRSO uptake, which is consistent with literature reports of 12–78% 14,24,27,36,41–68 . Uptake was higher among older women, women who completed childbearing, those who had BC themselves, and those having undergone RRM.…”
Section: Discussionsupporting
confidence: 92%
“…PBSO renders an anticipated early menopause which has unfortunate physical and psychological consequences ([ 39 , 40 ]). Premenopausal women undergoing PBSO experience hot flashes and night sweats (40%), dyspareunia (17%), and decreased libido (22%) [ 41 ].…”
Section: Prophylactic Bilateral Salpingo-oophorectomy (Pbso)mentioning
confidence: 99%
“…A study using anonymous questionnaires reveals that women who follow a surveillance program show a good level of satisfaction because it lowers the concerns of cancer risk. Satisfaction is also high in women undergoing risk reducing procedures mainly for the same reason [ 40 ]. The risk reduction benefit of RRM compared to surveillance has not been addressed in randomized studies.…”
Section: Surveillance As An Alternative To Risk Reducing Surgery In Female With Brca Mutationmentioning
confidence: 99%
“…Пациентам с мутациями в гене BRCA1 рекомендовано выполнение ПСОЭ в возрасте до 40 лет, после выполнения репродуктивной функции, тогда как для носителей мутаций в гене BRCA2 рекомендуемый возраст выполнения ПСОЭ выше на 10 лет. Кроме того, в данном исследовании проведен анализ качества жизни больных после выполнения ПСОЭ и сделан вывод о том, что двусторонняя ПСОЭ может снизить качество жизни женщин изза симптомов ранней менопаузы даже на фоне заместительной гормонотерапии [15].…”
Section: медико-генетическое консультированиеunclassified